---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-029482"
form_type: "8-K"
ticker: "FEED"
cik: "0001326706"
company_name: "ENvue Medical, Inc."
filed_at: "2025-12-30T23:59:59+00:00"
generated_at: "2026-05-16T11:57:50.139816+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# ENvue Medical amends 2024 Long Term Incentive Plan for Israeli tax compliance and name change

## Summary
- Board approved amended and restated 2024 Long Term Incentive Plan on December 24, 2025.
- Adds restricted stock units under Section 102 for Israeli tax compliance; other non-material updates.
- Reflects company name change from NanoVibronix to ENvue Medical and prior stockholder-approved amendment.

## SEC filing metadata
- accession: 0001493152-25-029482
- form_type: 8-K
- ticker: FEED
- cik: 0001326706
- company_name: ENvue Medical, Inc.
- filed_at: 2025-12-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326706/000149315225029482/0001493152-25-029482-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326706/000149315225029482/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-029482
- JSON: https://secwatch.observer/filing/0001493152-25-029482.json
- Plain text: https://secwatch.observer/filing/0001493152-25-029482.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.